tiprankstipranks
Olam Group (OLGPF)
OTHER OTC:OLGPF
Holding OLGPF?
Track your performance easily

Olam Group (OLGPF) Income Statement

4 Followers

Olam Group Income Statement

Last quarter (Q4 2022), Olam Group's total revenue was S$―, a decrease of ― from the same quarter last year. In Q4, Olam Group's net income was S$―. See Olam Group’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 22Dec 21Dec 20Dec 19Dec 18
Total Revenue
-S$ 54.90BS$ 47.00BS$ 35.82BS$ 32.99BS$ 30.48B
Cost of Revenue
-S$ -90.90MS$ 43.03BS$ 32.72BS$ 30.05BS$ 27.99B
Gross Profit
-S$ 54.99BS$ 3.98BS$ 3.10BS$ 2.94BS$ 2.49B
Operating Expense
-S$ 51.26BS$ 627.19MS$ 561.26MS$ 500.63MS$ 1.86B
Operating Income
-S$ 3.73BS$ 3.35BS$ 2.54BS$ 2.44BS$ 637.85M
Net Non Operating Interest Income Expense
-S$ -745.67MS$ -438.06MS$ -415.70MS$ -540.83MS$ -468.77M
Other Income Expense
------
Pretax Income
-S$ 727.18MS$ 736.74MS$ 222.18MS$ 333.11MS$ 380.62M
Tax Provision
-S$ 175.59MS$ 133.93MS$ 43.99MS$ 55.94MS$ 57.42M
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
-S$ 588.15MS$ 628.84MS$ 189.26MS$ 261.11MS$ 347.87M
Basic EPS
-S$ 0.16S$ 0.18S$ 0.06--
Diluted EPS
-S$ 0.15S$ 0.18S$ 0.06--
Basic Average Shares
-S$ 3.77BS$ 3.44BS$ 3.30B--
Diluted Average Shares
-S$ 3.83BS$ 3.49BS$ 3.35B--
Dividend Per Share
-S$ 0.09S$ 0.08S$ 0.03--
Total Operating Income As Reported
------
Reported Normalized Basic E P S
-S$ 0.20S$ 0.26S$ 0.19--
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
-S$ 51.17BS$ 43.65BS$ 33.28BS$ 30.55BS$ 29.84B
Net Income From Continuing And Discontinued Operation
-S$ 629.09MS$ 686.43MS$ 245.70MS$ 316.17MS$ 347.87M
Normalized Income
-S$ 626.97MS$ 674.96MS$ 185.54MS$ 203.82MS$ 318.54M
Interest Expense
-S$ 849.61MS$ 530.39MS$ 518.48MS$ 629.48MS$ 548.46M
EBIT
-S$ 1.58BS$ 1.27BS$ 740.65MS$ 962.59MS$ 929.08M
EBITDA
-S$ 2.29BS$ 1.89BS$ 1.30BS$ 1.46BS$ 1.32B
Currency in SGD

Olam Group Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis